These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9788621)

  • 41. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.
    Ye X; McCarrick J; Jewett L; Knowles BB
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3916-20. PubMed ID: 8171012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis.
    Christofori G; Naik P; Hanahan D
    Nature; 1994 Jun; 369(6479):414-8. PubMed ID: 7910953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unscheduled DNA replication precedes apoptosis of photoreceptors expressing SV40 T antigen.
    Al-Ubaidi MR; Mangini NJ; Quiambao AB; Myers KM; Abler AS; Chang CJ; Tso MO; Butel JS; Hollyfield JG
    Exp Eye Res; 1997 Apr; 64(4):573-85. PubMed ID: 9227276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness.
    Harlan DM; Hengartner H; Huang ML; Kang YH; Abe R; Moreadith RW; Pircher H; Gray GS; Ohashi PS; Freeman GJ
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3137-41. PubMed ID: 7512724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoaggression and tumor rejection: it takes more than self-specific T-cell activation.
    Ganss R; Limmer A; Sacher T; Arnold B; Hämmerling GJ
    Immunol Rev; 1999 Jun; 169():263-72. PubMed ID: 10450523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice.
    Martin DC; Rüther U; Sanchez-Sweatman OH; Orr FW; Khokha R
    Oncogene; 1996 Aug; 13(3):569-76. PubMed ID: 8760297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The immune response to sporadic colorectal cancer in a novel mouse model.
    Czéh M; Loddenkemper C; Shalapour S; Schön C; Robine S; Goldscheid E; Stein H; Schüler T; Willimsky G; Blankenstein T
    Oncogene; 2010 Dec; 29(50):6591-602. PubMed ID: 20818425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiple neuroendocrine tumours in transgenic mice induced by c-kit-SV40 T antigen fusion genes.
    Bossé P; Bernex F; De Sepulveda P; Salaün P; Panthier JJ
    Oncogene; 1997 Jun; 14(22):2661-70. PubMed ID: 9178764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncogenic co-operation in beta-cell tumorigenesis.
    Pelengaris S; Khan M
    Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physiologically based kinetic model of effector cell biodistribution in mammals: implications for adoptive immunotherapy.
    Zhu H; Melder RJ; Baxter LT; Jain RK
    Cancer Res; 1996 Aug; 56(16):3771-81. PubMed ID: 8706023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early immunization induces persistent tumor-infiltrating CD8+ T cells against an immunodominant epitope and promotes lifelong control of pancreatic tumor progression in SV40 tumor antigen transgenic mice.
    Otahal P; Schell TD; Hutchinson SC; Knowles BB; Tevethia SS
    J Immunol; 2006 Sep; 177(5):3089-99. PubMed ID: 16920946
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravital measurement of donor lymphocyte adhesion to islet endothelium of recipient animals in diabetes transfer experiments.
    Enghofer M; Bojunga J; Usadel KH; Kusterer K
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():99-102. PubMed ID: 8839263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice.
    Onrust SV; Hartl PM; Rosen SD; Hanahan D
    J Clin Invest; 1996 Jan; 97(1):54-64. PubMed ID: 8550850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice.
    Guerder S; Picarella DE; Linsley PS; Flavell RA
    Proc Natl Acad Sci U S A; 1994 May; 91(11):5138-42. PubMed ID: 7515187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen.
    Guerder S; Meyerhoff J; Flavell R
    Immunity; 1994 May; 1(2):155-66. PubMed ID: 7534199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The threshold for autoimmune T cell killing is influenced by B7-1.
    Allison J; Stephens LA; Kay TW; Kurts C; Heath WR; Miller JF; Krummel MF
    Eur J Immunol; 1998 Mar; 28(3):949-60. PubMed ID: 9541590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Compensatory apoptosis in response to SV40 large T antigen expression in the liver.
    Allemand I; Grimber G; Kornprobst M; Bennoun M; Molina T; Briand P; Joulin V
    Oncogene; 1995 Dec; 11(12):2583-90. PubMed ID: 8545115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene.
    Efrat S; Fusco-DeMane D; Lemberg H; al Emran O; Wang X
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3576-80. PubMed ID: 7724601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inducible and reversible beta-cell autoimmunity and hyperplasia in transgenic mice expressing a conditional oncogene.
    Berkovich I; Efrat S
    Diabetes; 2001 Oct; 50(10):2260-7. PubMed ID: 11574407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperplasia and tumors of the islets of Langerhans in mice bearing an elastase I-SV40 T-antigen fusion gene.
    Bell RH; Memoli VA; Longnecker DS
    Carcinogenesis; 1990 Aug; 11(8):1393-8. PubMed ID: 2167183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.